论文部分内容阅读
社区获得性肺炎(CAP)是指在医院外获得的感染性肺实质(含肺泡壁,即广义上的肺间质)炎症,包括具有明确潜伏期的病原体感染而在入院后平均潜伏期内发病的肺炎[1]。头孢地尼胶囊系日本藤泽药品株式会社开发的广谱口服第三代头孢菌素,其抗菌谱广,抗菌活性强,与其他第三代头孢菌素主要不同之处是增强了抗革兰阳性菌的抗菌活性,特别是对葡萄球菌、肺炎链球菌、肠杆菌属等有较强的抗菌活性。本文选择2009年1月～
Community acquired pneumonia (CAP) refers to inflammation of the parenchyma (including the alveolar walls, ie, interstitial lungs in the broad sense) acquired outside the hospital, including those with a clear latent period of infection of the pathogen and an average incubation period after admission [1]. Cefdinir capsules Japan’s Fujisawa Pharmaceutical Co., Ltd. developed a broad-spectrum oral third-generation cephalosporin, its broad antibacterial spectrum, strong antibacterial activity and other third-generation cephalosporins main difference is the enhanced anti-Gram Positive bacteria antibacterial activity, especially for Staphylococcus aureus, Streptococcus pneumoniae, Enterobacter genus have strong antibacterial activity. This article selects January 2009 ~